Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

US Patent 11427604 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2022
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2022